CN115343399B - Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug - Google Patents

Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug Download PDF

Info

Publication number
CN115343399B
CN115343399B CN202211271744.8A CN202211271744A CN115343399B CN 115343399 B CN115343399 B CN 115343399B CN 202211271744 A CN202211271744 A CN 202211271744A CN 115343399 B CN115343399 B CN 115343399B
Authority
CN
China
Prior art keywords
residual solvent
concentrations
temperature
alkyl pyrrolidone
stock solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211271744.8A
Other languages
Chinese (zh)
Other versions
CN115343399A (en
Inventor
邰丽
胡研
黄勤琴
陈伊杰
叶立文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Hequan Pharmaceutical Co ltd
Original Assignee
Changzhou Hequan Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Hequan Pharmaceutical Co ltd filed Critical Changzhou Hequan Pharmaceutical Co ltd
Priority to CN202211271744.8A priority Critical patent/CN115343399B/en
Publication of CN115343399A publication Critical patent/CN115343399A/en
Application granted granted Critical
Publication of CN115343399B publication Critical patent/CN115343399B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/60Construction of the column
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8624Detection of slopes or peaks; baseline correction
    • G01N30/8631Peaks

Abstract

The invention relates to a method for detecting a residual solvent of N-alkyl pyrrolidone in a bulk drug, which adopts a gas chromatograph to carry out detection and an external standard method to carry out quantitative analysis and comprises the following steps: weighing a test sample in a container, adding a diluent, and uniformly stirring for later use; weighing an object to be measured in a container, adding a diluent, and uniformly stirring; then preparing stock solutions of the substances to be detected with a plurality of concentrations; respectively injecting the test solution and the stock solutions of the substances to be tested with a plurality of concentrations into a gas chromatograph, and recording respective chromatograms; performing linear regression by using concentration data and peak areas of chromatograms obtained by measuring a plurality of concentrations of stock solutions of substances to be measured to obtain a regression equation and a correlation coefficient, and preparing a standard curve; and then calculating the content of the N-alkyl pyrrolidone according to an external standard method by utilizing the peak area in the chromatogram of the test solution. The method has the advantages of simple operation, good precision, high accuracy and low detection limit, and can be used for quality control of the residual solvent of the N-alkyl pyrrolidone.

Description

Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug
Technical Field
The invention relates to the technical field of analytical chemistry, in particular to a gas chromatography detection method for a residual solvent of N-alkyl pyrrolidone in a bulk drug.
Background
The use of solvents such as N-methyl pyrrolidone, N-ethyl pyrrolidone, N, N-dimethylformamide, N, N-dimethylacetamide and the like is limited and controlled by more and more domestic drug administration due to potential reproductive toxicity. N-N-butylpyrrolidone, N-isobutylpyrrolidone, N-t-butylpyrrolidone, N-N-pentylpyrrolidone, N-propylpyrrolidone substituted with a methyl group on the ring, N-butylpyrrolidone substituted with a methyl group on the ring, N-pentylpyrrolidone substituted with a methyl group on the ring, and the like have been shown to be non-reproductive toxic. Since they are high boiling, non-corrosive and polar compounds capable of dissolving a variety of other compounds, they are well suited as alternative solvents to N-methylpyrrolidone and the like, which are miscible with a variety of other solvents, including water, ethanol, diethyl ether, chloroform, benzene, ethyl acetate and carbon disulfide. But because it has no therapeutic effect, it should be removed as much as possible to meet the quality standards of the bulk drug and the preparation or other quality requirements.
At present, no report of quantitative related detection methods for the residual solvents of the N-alkyl pyrrolidone exists in the prior art, so an analysis method for detecting and controlling the residual solvents of the N-alkyl pyrrolidone in the bulk drugs needs to be established.
Disclosure of Invention
The invention aims to provide a method for detecting a residual solvent of N-alkyl pyrrolidone in a raw material medicine, which is simple to operate, accurate in result and high in sensitivity and effectively solves the problem that a related detection method is lacked in the prior art.
In order to solve the technical problems, the invention adopts the following technical scheme:
a detection method of residual solvent of N-alkyl pyrrolidone in bulk drugs adopts a gas chromatograph to carry out detection and an external standard method to carry out quantitative analysis, and comprises the following steps:
s1, preparing a test solution: weighing a test sample in a container, adding a diluent, and uniformly stirring for later use;
s2, preparing stock solution of the substance to be detected: weighing an object to be measured in a container, adding a diluent, and uniformly stirring; then preparing stock solutions of the substances to be detected with a plurality of concentrations;
s3, detecting by using a gas chromatograph: respectively injecting the test solution and the stock solutions of the substances to be tested with a plurality of concentrations into a gas chromatograph, and recording respective chromatograms;
and S4, analyzing the content of the N-alkyl pyrrolidone, and performing linear regression on the mass concentration and the peak area of a chromatogram obtained by measuring the stock solution of the substance to be measured with a plurality of concentrations to obtain a regression equation and a correlation coefficient to prepare a standard curve. And then, in a chromatogram for measuring the solution of the test sample, integrating chromatographic peaks of the N-alkyl pyrrolidone to obtain peak areas, and calculating according to an external standard method to obtain the content of the N-alkyl pyrrolidone.
Wherein the concentration of the test solution in the step S1 is 10-100mg/mL; in step S2, the stock solutions of the analyte have concentrations of 0.01mg/mL,0.05mg/mL,0.08mg/mL,0.1mg/mL,0.12mg/mL,0.15mg/mL and 0.2mg/mL, respectively.
The substance to be detected is one or more of N-N-butyl pyrrolidone, N-isobutyl pyrrolidone, N-tert-butyl pyrrolidone, N-N-amyl pyrrolidone, N-propyl pyrrolidone substituted by methyl on a ring, N-butyl pyrrolidone substituted by methyl on a ring and N-amyl pyrrolidone substituted by methyl on a ring.
And the diluent in the step S1 and the step S2 is one of five of water, N-dimethylformamide, N-dimethylacetamide, N-methylpyrrolidone and 1,3-dimethylimidazolidinone.
Wherein, the chromatographic conditions of the step S3 are as follows:
stationary phase of chromatographic column: 35% biphenyl/65% dimethylpolysiloxane; a detector: a hydrogen flame ionization detector; temperature programming procedure: starting temperature is 60-80 deg.C, maintaining for 0-1min, heating to 250-260 deg.C at a rate of 15-20 deg.C/min, and maintaining for 8-10 min; sample inlet temperature: 150-200 ℃; detector temperature: 250-300 ℃; carrier gas: nitrogen or helium; flow rate of carrier gas: 1.0-2.5mL/min; the split ratio is as follows: 5:1-20; and (3) sample introduction mode: directly feeding a sample; sample introduction volume: 0.5-10 μ L. The invention takes the boiling point of the object to be detected into full consideration, thereby designing a direct sample injection mode suitable for the detection method, and obtaining better peak shape and separation effect with other impurities under the condition.
According to the detection method for the N-alkyl pyrrolidone residual solvent in the bulk drugs, the conventional gas chromatography is adopted, the polysiloxane capillary column chromatographic column is selected, the test sample and the stock solution of the to-be-detected substance are simple to process, the result is accurate, the sensitivity is high, the stability is good, 0.01mg of N-alkyl pyrrolidone contained in the bulk drugs can be detected, and the quality control problem of the N-alkyl pyrrolidone residual solvent in the bulk drugs is solved.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention. In the drawings:
FIG. 1 is a chromatogram of a blank solution of the present invention;
FIG. 2 is a chromatogram of a test solution according to the present invention;
FIG. 3 is a chromatogram of a stock solution of an analyte of the present invention;
FIG. 4 is a chromatogram of a sample recovery solution according to the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Instrument and reagent
The instrument comprises the following steps:
gas chromatograph: agilent 7820A/7697 gas chromatograph; parts per million analytical balance: mettler Toledo XSE205DU;
reagent:
n, N-dimethylformamide: j & K chromatographic purity
(II) gas chromatography detection conditions
And (3) chromatographic column: restek RTX-35 Amine (30 m × 0.32mm, 1 μm); a detector: a hydrogen flame ionization detector;
temperature programming procedure: the initial temperature is 80 ℃, the temperature is kept for 0min, the temperature is raised to 260 ℃ at the heating rate of 20 ℃/min, and the temperature is kept for 8 min; sample inlet temperature: 200 ℃; detector temperature: 280 ℃; carrier gas (helium) flow rate: 2.0mL/min; the split ratio is as follows: 15; sample injection volume: 1 μ L.
(III) Experimental part-solution preparation
Preparing a diluent: n, N-dimethylformamide as a diluent;
preparing a blank solution: n, N-dimethylformamide is used as a blank solution;
preparing a test solution: taking 1000mg of a raw material medicine sample, precisely weighing, placing in a 10mL volumetric flask, fixing the volume to a scale with a diluent, and shaking up to be used as a test solution;
preparing stock solution of a substance to be detected: taking 100mg of N-N-butyl pyrrolidone standard substance, precisely weighing, placing in a 10mL volumetric flask, diluting to a constant volume with a diluent, shaking up, and taking as stock solution (1 mg/mL) of the substance to be detected;
test sample recovery rate solution: 1000mg of a raw material medicine sample is taken, precisely weighed and placed in a 10mL volumetric flask, 1mL of stock solution of the substance to be detected is respectively added, and the volume is determined to the scale by using a diluent to be used as a solution with 100% recovery rate.
(IV) methodological investigation
1) Specificity test
And (3) sampling blank solution, test sample solution, stock solution of the substance to be tested and recovery rate solution of the test sample respectively to acquire chromatogram maps, and obtaining results shown in figures 1 to 4. The test result shows that the blank solution has no interference, and other peaks in the sample have no interference to the chromatographic peak of N-N-butyl pyrrolidone, i.e. the method has better specificity.
2) Precision test
Diluting the stock solution of the substance to be detected to 0.1mg/mL, continuously injecting samples for 5 times under the gas chromatography detection condition of the second part, injecting samples with volume of 1 mu L, injecting the samples into a chromatograph, recording retention time and peak area, and evaluating the result, wherein the result is shown in Table 1.
TABLE 1 results of systematic precision test
Figure 912838DEST_PATH_IMAGE001
The result shows that the method has good system precision and meets the test requirement.
3) Linear and range test
Precisely transferring a proper amount of N-N-butyl pyrrolidone stock solution, and diluting with diluent to the concentration of 0.01mg/mL,0.05mg/mL,0.1mg/mL,0.15mg/mL and 0.2mg/mL. The solutions were injected into a gas chromatograph, and the sample injection volume was 1 μ L, and linear regression was performed using the mass concentration and peak area to obtain a regression equation and correlation coefficients y =534.23x-0.5376 and 0.9995, respectively, the results of which are shown in table 2.
TABLE 2N-n-butylpyrrolidone Linear and Range test results
Figure 502082DEST_PATH_IMAGE002
The results show that the linearity of N-N-butylpyrrolidone is good in the range of 0.01mg/mL to 0.2mg/mL.
4) Testing of detection limit and quantification limit
Adjusting the sensitivity of the instrument, taking a proper amount of N-N-butyl pyrrolidone stock solution, gradually diluting and injecting samples with the sample injection volume of 1 mu L to ensure that the main peak height is 2-3 times of the baseline noise, and recording a chromatogram map to obtain the minimum detection limit of the N-N-butyl pyrrolidone of 0.005mg/mL.
Adjusting the sensitivity of the instrument, taking a proper amount of N-N-butyl pyrrolidone stock solution, gradually diluting and injecting samples, injecting the sample with the volume of 1 mu L, enabling the main peak height to be 10 times of the baseline noise, and recording a chromatogram map to obtain the minimum detection limit of the N-N-butyl pyrrolidone to be 0.01mg/mL.
5) Standard recovery test
And (3) injecting the sample solution and the sample recovery rate solution into a gas chromatograph, wherein the sample injection volume is 1 mu L, and the concentration of each peak in the recovery rate solution is calculated according to an external standard method, and the test result is shown in table 3.
TABLE 3 results of the normalized recovery test
Figure 265508DEST_PATH_IMAGE003
The result shows that the method has high accuracy and meets the test requirement.
6) Stability test of solution
The recovery rate solution (100%) was allowed to stand at room temperature for 26 hours, and the stability of the solution was examined. According to the conditions of the gas chromatography in the second part, the mixture was injected into the chromatograph at 0,5, 16, 20 and 26 hours, respectively, the injection volume was 1 μ L, and the chromatogram was recorded, and the results are shown in Table 4.
TABLE 4 recovery rate solution stability test
Figure 598400DEST_PATH_IMAGE004
The result shows that the recovery rate solution is placed for 26 hours at room temperature, and the stability of the solution is good.
The present invention is not limited to the above embodiments, and those skilled in the art can make various equivalent changes and substitutions without departing from the principle of the present invention after learning the content of the present invention, and these equivalent changes and substitutions should be considered as belonging to the protection scope of the present invention.

Claims (4)

1. A method for detecting residual solvent of N-alkyl pyrrolidone in bulk drugs is characterized in that a gas chromatograph is used for detection and an external standard method is used for quantitative analysis, and the method comprises the following steps:
s1, preparing a test solution: weighing a test sample in a container, adding a diluent, and uniformly stirring for later use;
s2, preparing stock solution of the substance to be detected: weighing an object to be measured in a container, adding a diluent, and uniformly stirring; then preparing stock solutions of the substances to be detected with a plurality of concentrations;
s3, detecting by using a gas chromatograph: respectively injecting the test solution and the stock solutions of the substances to be tested with a plurality of concentrations into a gas chromatograph, and recording respective chromatograms;
s4, analyzing the content of N-alkyl pyrrolidone: performing linear regression by using concentration data and peak areas of chromatograms obtained by measuring stock solutions of objects to be measured with a plurality of concentrations to obtain a regression equation and a correlation coefficient, and preparing a standard curve; then, calculating the content of the N-alkyl pyrrolidone according to an external standard method by utilizing the peak area in the chromatogram of the test solution;
the substance to be detected in the step S2 is N-N-butyl pyrrolidone;
the chromatographic conditions of step S3 are:
stationary phase of chromatographic column: 35% biphenyl/65% dimethylpolysiloxane; a detector: a hydrogen flame ionization detector;
temperature programming procedure: the initial temperature is 80 ℃, the temperature is kept for 0min, the temperature is raised to 260 ℃ at the heating rate of 20 ℃/min, and the temperature is kept for 8 min; sample inlet temperature: 200 ℃; detector temperature: 280 ℃; helium as carrier gas, carrier gas flow rate: 2.0mL/min; the split ratio is as follows: 15; sample introduction volume: 1 μ L.
2. The method for detecting the residual solvent of N-alkylpyrrolidone in the bulk drug according to claim 1, which is characterized in that: the concentration of the sample solution in the step S1 is 10-100mg/mL.
3. The method for detecting the residual solvent of N-alkylpyrrolidone in the bulk drug according to claim 1, which is characterized in that: in step S2, the stock solutions of the analyte have concentrations of 0.01mg/mL,0.05mg/mL,0.08mg/mL,0.1mg/mL,0.12mg/mL,0.15mg/mL and 0.2mg/mL, respectively.
4. The method for detecting the residual solvent of N-alkylpyrrolidone in the bulk drug according to claim 1, which is characterized in that: the diluent in the step S1 and the step S2 is one of water, N-dimethylformamide, N-dimethylacetamide, N-methylpyrrolidone and 1,3-dimethylimidazolidinone.
CN202211271744.8A 2022-10-18 2022-10-18 Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug Active CN115343399B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211271744.8A CN115343399B (en) 2022-10-18 2022-10-18 Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211271744.8A CN115343399B (en) 2022-10-18 2022-10-18 Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug

Publications (2)

Publication Number Publication Date
CN115343399A CN115343399A (en) 2022-11-15
CN115343399B true CN115343399B (en) 2023-03-03

Family

ID=83957429

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211271744.8A Active CN115343399B (en) 2022-10-18 2022-10-18 Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug

Country Status (1)

Country Link
CN (1) CN115343399B (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
毛细管气相色谱法测定JS1-1-01原料药中溶剂残留量;闫丽晔 等;《沈阳药科大学学报》;20200228;第37卷(第2期);摘要,第148页右栏至第149页 *
气质联用法快速测定8种挥发性有机溶剂;俞凌云 等;《印染》;20151231;第7卷;全文 *
花生油香气特征在其属性识别中的初步应用;李苑雯 等;《食品与发酵工业》;20131231;第39卷(第7期);全文 *

Also Published As

Publication number Publication date
CN115343399A (en) 2022-11-15

Similar Documents

Publication Publication Date Title
CN103487519B (en) A kind of detect the method for multiple residual solvent in medicine
CN104655751B (en) A kind of detect the method for organic solvent residual in dapoxetine
CN110031573B (en) Method for measuring vitamin D content by two-dimensional column switching high performance liquid chromatography
CN106770788A (en) Numb-taste components content detection based on " one surveys comment more " method
CN111929384A (en) Method for determining content of residual methyl siloxane in organic silicon softening agent by using HS-GC external standard method
CN115343399B (en) Method for detecting residual solvent of N-alkyl pyrrolidone in bulk drug
CN109799298B (en) Detection method of related substances in Perampanel bulk drug
CN111289662A (en) Method for analyzing residual solvent in enoxaparin sodium
CN110895264A (en) Method for determining ethyl bromide in tenofovir alafenamide
CN108572223B (en) Method for determining activity inducing substance in polypeptide
CN108593796A (en) A method of detection bulk pharmaceutical chemicals Austria is uncommon for organic residual solvent in Buddhist nun
CN107966498B (en) Method for detecting solvent residue in Idelalis
CN110412164A (en) A kind of detection method of the related substance of mexiletine hydrochloride
CN109507336B (en) Method for detecting organic solvent residue in glutamine dipeptide
CN114839300B (en) Method for measuring 6 chemical components in fingered citron by adopting one-measurement-multiple-evaluation method
CN111595954B (en) Method for detecting content of DCC and DCU in indapamide bulk drug
CN108107138A (en) The method that HPLC-CAD measures glucose in Dextrose and Sodium Chloride Inj.
CN108344813A (en) The method that HPLC-CAD measures sodium content in Dextrose and Sodium Chloride Inj.
CN112684039B (en) Method for detecting residual quantity of organic solvent in imatinib raw material medicine
CN113777204B (en) Detection method of p-hydroxyacetophenone related substances
CN112730642B (en) Method for simultaneously detecting methyl trifluoromethanesulfonate and ethyl trifluoromethanesulfonate in tubulin inhibitor bulk drug
CN109557213B (en) Quantitative determination of DNAN content by GC-AED irrelevant calibration curve method (CIC method)
CN114062562A (en) Method for detecting formaldehyde carbonylation reaction product by high performance liquid chromatography
CN114609277A (en) Method for measuring content of compound acetylsalicylic acid tablet
CN115980226A (en) Method for determining residual amount of trichloromethane in nitrophenylpyridone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant